Cargando…

Hypoglycemic agents and glycemic variability in individuals with type 2 diabetes: A systematic review and network meta-analysis

While hemoglobin A1c (HbA1c) is commonly used to monitor therapy response in type 2 diabetes (T2D), GV is emerging as an essential additional metric for optimizing glycemic control. Our goal was to learn more about the impact of hypoglycemic agents on HbA1c levels and GV in patients with T2D. A syst...

Descripción completa

Detalles Bibliográficos
Autores principales:	Oh, SuA, Purja, Sujata, Shin, Hocheol, Kim, Minji, Kim, Eunyoung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9189550/ https://www.ncbi.nlm.nih.gov/pubmed/35686694 http://dx.doi.org/10.1177/14791641221106866

Ejemplares similares

Efficacy, Immunogenicity, and Safety of COVID-19 Vaccines in Randomized Control Trials in the Pre-Delta Era: A Systematic Review and Network Meta-Analysis
por: Oh, SuA, et al.
Publicado: (2022)

The Adverse Effects and Nonmedical Use of Methylphenidate Before and After the Outbreak of COVID-19: Machine Learning Analysis
por: Shin, Hocheol, et al.
Publicado: (2023)

A Systematic Review on Neurological Aspects of COVID-19: Exploring the Relationship Between COVID-19-Related Olfactory Dysfunction and Neuroinvasion
por: Purja, Sujata, et al.
Publicado: (2022)

Is loss of smell an early predictor of COVID-19 severity: a systematic review and meta-analysis
por: Purja, Sujata, et al.
Publicado: (2021)

Assessment of the reporting quality of randomized controlled trials related to the pharmacotherapy of COVID-19 based on the CONSORT 2010 checklist: a systematic review
por: Jung, Youn-Joo, et al.
Publicado: (2022)

Factors Associated with Glycemic Variability in Patients with Type 2 Diabetes: Focus on Oral Hypoglycemic Agents and Cardiovascular Risk Factors
por: Yoo, Soyeon, et al.
Publicado: (2015)

Glycemic Variability Correlates Strongly With Postprandialβ-Cell Dysfunction in a Segment of Type 2 Diabetic Patients Using Oral Hypoglycemic Agents
por: Kohnert, Klaus-Dieter, et al.
Publicado: (2009)

Comparative Impact of PD-1 and PD-L1 Inhibitors on Advanced Esophageal or Gastric/Gastroesophageal Junction Cancer Treatment: A Systematic Review and Meta-Analysis
por: Oh, SuA, et al.
Publicado: (2021)

Effect of Dapagliflozin on Glycemic Variability in Patients with Type 2 Diabetes under Insulin Glargine Combined with Other Oral Hypoglycemic Drugs
por: Luo, Menghui, et al.
Publicado: (2020)

Effect of DPP-IV Inhibitors on Glycemic Variability in Patients with T2DM: A Systematic Review and Meta-Analysis
por: Lee, Subin, et al.
Publicado: (2019)

Hypoglycemic agents and incidence of pancreatic cancer in diabetic patients: a meta-analysis
por: Zhao, Zimo, et al.
Publicado: (2023)

Effect of high-dose zinc supplementation with oral hypoglycemic agents on glycemic control and inflammation in type-2 diabetic nephropathy patients
por: Khan, Mohd Idreesh, et al.
Publicado: (2013)

Hypoglycemic agents for non-alcoholic fatty liver disease with type 2 diabetes mellitus: A protocol for systematic review and network meta-analysis
por: Liu, Su-Tong, et al.
Publicado: (2020)

The Management of Type 2 Diabetic Patients with Hypoglycemic Agents
por: Carnevale Schianca, G. P., et al.
Publicado: (2012)

Meta-analysis of the association between new hypoglycemic agents and digestive diseases
por: Wang, Yu-Wen, et al.
Publicado: (2022)

Efficacy of Various Hypoglycemic Agents in the Treatment of Patients With Nonalcoholic Liver Disease With or Without Diabetes： A Network Meta-Analysis
por: Lian, Jingxuan, et al.
Publicado: (2021)

Adherence to Oral Hypoglycemic Agents in Hawaii
por: Lee, Rachel, et al.
Publicado: (2005)

Combination therapy of oral hypoglycemic agents in patients with type 2 diabetes mellitus
por: Moon, Min Kyong, et al.
Publicado: (2017)

Combination Therapy of Oral Hypoglycemic Agents in Patients with Type 2 Diabetes Mellitus
por: Moon, Min Kyong, et al.
Publicado: (2017)

Factors Associated with Long-Term Oral Hypoglycemic Agent Responsiveness in Korean Patients with Type 2 Diabetes Mellitus
por: Kim, Bo-Yeon, et al.
Publicado: (2011)

Bioactives of Momordica charantia as Potential Anti-Diabetic/Hypoglycemic Agents
por: Xu, Bilin, et al.
Publicado: (2022)

Hypoglycemic agents and potential anti-inflammatory activity
por: Kothari, Vishal, et al.
Publicado: (2016)

Post-Hypoglycemic hyperglycemia are highly relevant markers for stratification of glycemic variability and partial remission status of pediatric patients with new-onset type 1 diabetes
por: Harvengt, Antoine A., et al.
Publicado: (2023)

Tight Glycemic Control and Use of Hypoglycemic Medications in Older Veterans With Type 2 Diabetes and Comorbid Dementia
por: Thorpe, Carolyn T., et al.
Publicado: (2015)

Effect of hypoglycemic agents on survival outcomes of lung cancer patients with diabetes mellitus: A meta-analysis
por: Xin, Wen-Xiu, et al.
Publicado: (2018)

Individual Postprandial Glycemic Responses to Meal Types by Different Carbohydrate Levels and Their Associations with Glycemic Variability Using Continuous Glucose Monitoring
por: Song, Jiwoo, et al.
Publicado: (2023)

Pharmacogenetics in type 2 diabetes: influence on response to oral hypoglycemic agents
por: Dawed, Adem Yesuf, et al.
Publicado: (2016)

Oral hypoglycemic agents: do the ends justify the means?
por: Langer, Oded
Publicado: (2015)

Utility of Hypoglycemic Agents to Treat Asthma with Comorbid Obesity
por: Ge, Derek, et al.
Publicado: (2022)

A Meta-Analysis of the Efficacy of Prokinetic Agents against Glycemic Control
por: Kim, Yeon-Ji, et al.
Publicado: (2019)

Conversational Agents for Body Weight Management: Systematic Review
por: Noh, Eunyoung, et al.
Publicado: (2023)

Latent autoimmune diabetes of adults: From oral hypoglycemic agents to early insulin
por: Poudel, Resham R.
Publicado: (2012)

Drug-drug interaction between voriconazole and oral hypoglycemic agents in diabetic rats
por: Kumar, Boyina Hemanth, et al.
Publicado: (2013)

Evaluation of Adherence to Oral Hypoglycemic Agent Prescription in Patients with Type 2 Diabetes
por: Irani, Mahtab, et al.
Publicado: (2021)

Is There Evidence That Oral Hypoglycemic Agents Reduce Cardiovascular Morbidity or Mortality? No
por: Kassem, Sameer A., et al.
Publicado: (2009)

Nephroprotection by Hypoglycemic Agents: Do We Have Supporting Data?
por: Górriz, Jose Luis, et al.
Publicado: (2015)

Efficacy and safety of hypoglycemic agents on gestational diabetes mellitus in women: A Bayesian network analysis of randomized controlled trials
por: Wang, Ting, et al.
Publicado: (2022)

Significance of Glycemic Variability in Diabetes Mellitus
por: Kusunoki, Yoshiki, et al.
Publicado: (2021)

Effective Utilization of Oral Hypoglycemic Agents to Achieve Individualized HbA1c Targets in Patients with Type 2 Diabetes Mellitus
por: Bannister, Margaret, et al.
Publicado: (2016)

Metformin May Contribute to Inter-individual Variability for Glycemic Responses to Exercise
por: Malin, Steven K., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_pcunste28lq68mm2afaard1cem